Many factors must be considered and discussed with women when initiating a contraceptive
method and the risk of venous thromboembolism (VTE) is one of them. In this review, we …

The risk of venous thrombosis (VT) varies according to the type of progestogen that is found
in combined oral contraceptives (COCs). When combined with the estrogen component …

Introduction Currently available combined oral contraceptives (COC) reportedly increase the
risk of venous thromboembolism (VTE). We aimed to quantify this risk considering both …

Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

For many years, it has been well documented that combined hormonal contraceptives
increase the risk of venous thromboembolism (VTE). The third-generation pill use …

Background: An association between oral contraceptive (OC) use and venous
thromboembolism (VTE) has long been recognized. However, no summary estimates of the …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …

Background Combined oral contraceptive (COC) use has been associated with venous
thrombosis (VT)(ie, deep venous thrombosis and pulmonary embolism). The VT risk has …

Combined oral contraceptives, oral hormone replacement therapy and thrombophilias are
recognised risk factors for venous thromboembolism in women. The objective of this study …

Essentials• We performed a meta‐analysis on thrombosis risk in thrombophilic oral
contraceptive (COC)‐users.• The results support discouraging COC‐use in women with a …